Marginal zone lymphoma treatment evolves with promising CAR T-cell therapies, addressing unmet needs in aggressive cases and improving patient outcomes.
In mantle cell lymphoma (MCL), an aggressive form of B-cell non-Hodgkin lymphoma, TP53 mutations are known to affect patients’ prognosis—but questions remain. What does the heterogeneity of TP53 ...
Patients with Waldenström Non-Hodgkin lymphoma in the U.S. achieved durable complete responses of up to 15 months using a chemotherapy-free CD19 CAR-NK (chimeric antigen receptor natural killer) cell ...
The FDA has granted orphan drug designation (ODD) to LP-284, a next-generation acylfulvene small molecule, for the treatment ...
Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...
Integration of targeted therapies and immunotherapies offers new hope, enhancing survival rates and quality of life. Patients with mantle cell lymphoma experienced better survival rates when treated ...
Dr. Ian Flinn explains in an interview with CURE how Lunsumio VELO (mosunetuzumab) works and its impact on patients with ...
Teens with advanced-stage Hodgkin lymphoma survive longer without their disease getting worse when they receive the ...
(MENAFN- GetNews) The Key Cutaneous T-cell Lymphoma Companies in the market include - Citius Pharmaceuticals, Soligenix, 4SC AG, Innate Pharma, Galderma R&D, Kyowa Kirin, Inc, oligenix, Ligand ...
ORLANDO, Fla. — A pair of studies offer new insights into treatments for newly diagnosed advanced-stage Hodgkin lymphoma (ASHL). One confirmed that long-term outcomes for the regimen known as ...
A research team at Kyoto University has discovered STAG3-cohesin, a new mitotic cohesin complex that helps establish the unique DNA architecture of spermatogonial stem cells (SSCs), the stem cells ...
PATIENTS with primary Sjögren’s disease (SjD) face a higher risk of developing B cell lymphoma, but molecular predictors of this complication remain poorly understood. Scientists used targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results